These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6102257)

  • 1. Immunological influence of amniotic fluid.
    Gleicher N
    Lancet; 1980 Mar; 1(8167):541. PubMed ID: 6102257
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor.
    Abramsky O; Brenner T; Lisak RP; Zeidman A; Beyth Y
    Lancet; 1979 Dec 22-29; 2(8156-8157):1333-5. PubMed ID: 92675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of the fetus against infection.
    Larsen B; Galask RP
    Semin Perinatol; 1977 Apr; 1(2):183-93. PubMed ID: 382363
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukocyte migration enhancement as an indicator of immunologic enhancement. I. Pregnancy.
    Gleicher N; Beers P; Kerenyi TD; Cohen CJ; Gusberg SB
    Am J Obstet Gynecol; 1980 Jan; 136(1):1-4. PubMed ID: 7352471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-erythrocytic feto-maternal immunizations].
    Ducos J
    Rev Fr Transfus; 1969; 12(1):Suppl:221-43. PubMed ID: 4913461
    [No Abstract]   [Full Text] [Related]  

  • 6. Fetal- and uterine-specific antigens in human amniotic fluid.
    Sutcliffe RG; Brock DJ; Nicholson LV; Dunn E
    J Reprod Fertil; 1978 Sep; 54(1):85-90. PubMed ID: 712715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic potentials of determining the Rh(D) phenotype of the fetus and the Rh antibody titer of the amniotic fluid in Rh immunization].
    Vitanova R
    Akush Ginekol (Sofiia); 1985; 24(6):46-9. PubMed ID: 3937457
    [No Abstract]   [Full Text] [Related]  

  • 8. Amniotic fluid assessement of Jra-sensitized pregnant patients.
    Toy PT; Reid M; Lewis T; Ellisor S; Avoy DR
    Am J Obstet Gynecol; 1981 Jun; 140(3):352. PubMed ID: 7246647
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the concentrations of interleukin 15 in amniotic fluid in the second and the third trimesters of pregnancy.
    Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R
    Adv Clin Exp Med; 2012; 21(1):75-9. PubMed ID: 23214303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological properties of the amniotic fluid in physiological pregnancy and gestoses].
    Starostina TA; Kudriashova NM; Belokrinitskiĭ DV; Razmakhnina NI; Seredina TA
    Akush Ginekol (Mosk); 1991 Dec; (12):10-2. PubMed ID: 1789334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine.
    Bry K; Lappalainen U; Waffarn F; Teramo K; Hallman M
    Pediatr Res; 1994 Jan; 35(1):130-4. PubMed ID: 8134191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the concentrations of interleukin 18 in amniotic fluid in the second and the third trimesters of pregnancy.
    Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R
    Adv Clin Exp Med; 2013; 22(5):699-703. PubMed ID: 24285455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
    Hackmon R; Hallak M; Krup M; Weitzman D; Sheiner E; Kaplan B; Weinstein Y
    Fetal Diagn Ther; 2004; 19(5):404-9. PubMed ID: 15305096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A blocking factor in amniotic fluid causing leukocyte migration enhancement.
    Gleicher N; Cohen CJ; Kerenyi TD; Gusberg SB
    Am J Obstet Gynecol; 1979 Feb; 133(4):386-90. PubMed ID: 434001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydramnios].
    Kosheleva NG; Iartseva MA
    Sov Med; 1986; (8):62-7. PubMed ID: 3535110
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic and prognostic value of an immunological method for demonstrating effusing amniotic fluid in early pregnancy].
    Genov M; Tiutiundzhiev T
    Akush Ginekol (Sofiia); 1979; 18(6):417-21. PubMed ID: 525717
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue-specific autoimmune diseases in pregnancy.
    Jones WR
    Clin Obstet Gynaecol; 1979 Dec; 6(3):473-91. PubMed ID: 389525
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukocyte migration enhancement as an indicator of immunologic enhancement. III. Common denominators of pregnancy and malignancy.
    Gleicher N; Beers P; Cohen CJ; Kerenyi TD; Gusberg SB
    Am J Obstet Gynecol; 1980 Jan; 136(1):5-10. PubMed ID: 7352487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester IL-15 and IL-18 levels in the amniotic fluid of fetuses with normal karyotypes and with chromosome abnormalities.
    Klimkiewicz-Blok D; Florjański J; Zalewski J; Blok R
    Adv Clin Exp Med; 2012; 21(2):201-5. PubMed ID: 23214284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of leukocyte migration induced by sera of patients with Basedow's disease of autimmune diseases].
    Puppo F; Di Benedetto G; Barabino A; Soldà AM; Priolo C; Indiveri F
    Boll Soc Ital Biol Sper; 1977 Apr; 53(7):531-7. PubMed ID: 578774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.